Cargando…

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal

Rebamipide was initially developed and approved for use in treating gastric ulcers and lesions associated with gastritis. Discovery of its ability to increase gastric mucin led to investigations of its effect on ocular surface mucin and the subsequent development for use in dry eye patients. Investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kashima, Tomoyuki, Itakura, Hirotaka, Akiyama, Hideo, Kishi, Shoji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051796/ https://www.ncbi.nlm.nih.gov/pubmed/24940041 http://dx.doi.org/10.2147/OPTH.S40798

Ejemplares similares

Topical rebamipide improves lid wiper epitheliopathy
por: Itakura, Hirotaka, et al.
Publicado: (2013)

Topical rebamipide improves the ocular surface in mild lagophthalmos
por: Itakura, Mariko, et al.
Publicado: (2013)

Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
por: Ueda, Kaori, et al.
Publicado: (2015)

Resolution of persistent corneal erosion after administration of topical rebamipide
por: Kashima, Tomoyuki, et al.
Publicado: (2012)

Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren’s syndrome-associated dry eyes
por: Shoji, Jun, et al.
Publicado: (2020)

Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients
por: Sakane, Yuri, et al.
Publicado: (2019)

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
por: Shrivastava, Saurabh, et al.
Publicado: (2018)

Corrigendum to “Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients”
por: Sakane, Yuri, et al.
Publicado: (2020)

Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre
por: Jain, Kalpna, et al.
Publicado: (2023)

The Efficacy and Safety of Rebamipide Ophthalmic Suspension (OPC-12759) in Patients with Dry Eye Disease: A Systematic Review of Randomized Controlled Trials
por: Ballesteros-Sánchez, Antonio, et al.
Publicado: (2023)

Evaluation of dacryocystorhinostomy using optical coherence tomography and rebamipide ophthalmic suspension
por: Fujimoto, Masahiro, et al.
Publicado: (2014)

Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
por: Sasaki, Hidenori, et al.
Publicado: (2014)

Retinal ganglion cell analysis in multiple evanescent white dot syndrome
por: Akiyama, Hideo, et al.
Publicado: (2014)

Asymmetric severity of diabetic retinopathy in Waardenburg syndrome
por: Kashima, Tomoyuki, et al.
Publicado: (2011)

Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice
por: Fu, Rongrong, et al.
Publicado: (2019)

The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress
por: Simsek, Cem, et al.
Publicado: (2019)

Case Report: A Rare Orbital Abscess Caused by Dacryocystitis After Administration of Rebamipide Ophthalmic Suspension
por: Imamura, Hitoshi, et al.
Publicado: (2021)

Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye
por: Igarashi, Tsutomu, et al.
Publicado: (2018)

The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye
por: Teshigawara, Takeshi, et al.
Publicado: (2022)

Improved subjective symptoms of conjunctivochalasis using bipolar diathermy method for conjunctival shrinkage
por: Kashima, Tomoyuki, et al.
Publicado: (2011)

Alteration of choroidal thickness in a case of carotid cavernous fistula: a case report and a review of the literature
por: Shinohara, Yoichiro, et al.
Publicado: (2013)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles
por: Nagai, Noriaki, et al.
Publicado: (2020)

Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease
por: Venkateswaran, Nandini, et al.
Publicado: (2022)

Irrational ophthalmic fixed-dose combinations for dry eye syndrome
por: Kshirsagar, Nilima A, et al.
Publicado: (2022)

The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease
por: Simsek, Cem, et al.
Publicado: (2019)

Evaluation of Fundus Blood Flow in Normal Individuals and Patients with Internal Carotid Artery Obstruction Using Laser Speckle Flowgraphy
por: Shinohara, Yoichiro, et al.
Publicado: (2017)

Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes
por: Hayashi, Yusuke, et al.
Publicado: (2016)

Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial
por: Eom, Youngsub, et al.
Publicado: (2023)

Animal-type malignant melanoma associated with nevus of Ota in the orbit of a Japanese woman: a case report
por: Nitta, Keisuke, et al.
Publicado: (2014)

Impact of Perioperative Dry Eye Treatment with Rebamipide Versus Artificial Tears on Visual Outcomes After Cataract Surgery in Japanese Population
por: Teshigawara, Takeshi, et al.
Publicado: (2022)

Effects of Rebamipide on Differences in Power and Axis of Corneal Astigmatism Between Two Intra-patient Keratometric Measurements in Dry Eyes
por: Teshigawara, Takeshi, et al.
Publicado: (2021)

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
por: Nguyen, Theresa, et al.
Publicado: (2011)

Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery
por: Reddy, Rahul, et al.
Publicado: (2011)

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)

The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye
por: Hovanesian, John A, et al.
Publicado: (2022)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White, Darrell E, et al.
Publicado: (2019)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
por: Gaynes, Bruce I, et al.
Publicado: (2008)

Vortex vein congestion in the monkey eye: A possible animal model of pachychoroid
por: Matsumoto, Hidetaka, et al.
Publicado: (2022)

Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
por: Matossian, Cynthia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_etia8pd54s9fbolaodsbv19bgd